LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

Kodu・Aktsiate loetelu・Medpace Holdings Inc

Medpace Holdings Inc

Suletud

SektorTervishoid

496.75 1.32

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

482.71

Max

503.67

Põhinäitajad
By Trading Economics
Sissetulek	-24M 90M
Müük	45M 603M
P/E Sektori keskmine	36.908 35.293
Aktsiakasum	3.67
Kasumimarginaal	14.961
Töötajad	6,000
EBITDA	-2.8M 118M

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	-14.34% downside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	20. okt 2025

Turustatistika
By TradingEconomics
Turukapital	5.1B 14B
Eelmine avamishind	495.43
Eelmine sulgemishind	496.75

Uudiste sentiment

By Acuity

100%

353 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

300 / 302.88 Toetus ja vastupanu

Medpace Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

17. sept 2025, 23:01 UTC

Omandamised, ülevõtmised, äriostud

Santos Confirms XRG Consortium Pulls $18.7 Billion Takeover Bid -- Update

17. sept 2025, 22:48 UTC

Omandamised, ülevõtmised, äriostud

Santos Confirms XRG Consortium Pulls $18.7 Billion Takeover Bid

17. sept 2025, 21:59 UTC

Tulu

Cryptocurrency-Exchange Bullish Swings to Profit in First Report as Public Company

17. sept 2025, 23:44 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

17. sept 2025, 23:39 UTC

Market Talk

Gold Rises Amid Prospects of Further Fed Rate Cuts -- Market Talk

17. sept 2025, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Santos: XRG Consortium Wouldn't Agree to Appropriate Risk Allocation Between It and Santos Shareholders

17. sept 2025, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Santos: XRG Consortium Wouldn't Agree to Acceptable Terms That Protected Value of Transaction

17. sept 2025, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Santos Had Expressed Concern to XRG Consortium About Delays in Agreeing to Scheme Implementation Agreement

17. sept 2025, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Santos: Consortium Notified Board of Decision to Withdraw Proposal on Weds Evening

17. sept 2025, 22:18 UTC

Omandamised, ülevõtmised, äriostud

Santos Confirms XRG Consortium Has Withdrawn Takeover Proposal

17. sept 2025, 21:00 UTC

Tulu

Darden Restaurants to Report Earnings. Why the Olive Garden Parent Is Expected to Stay Strong. -- Barrons.com

17. sept 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

17. sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. sept 2025, 19:59 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. sept 2025, 19:59 UTC

Market Talk

Treasury Yields, Dollar Rise as Fed Cuts, Powell Warns of Risks -- Market Talk

17. sept 2025, 19:07 UTC

Market Talk

Oil Futures Snap Three-Session Winning Streak -- Market Talk

17. sept 2025, 18:43 UTC

Market Talk

Treasury Yields, Dollar Reverse Course as Powell Talks to Reporters -- Market Talk

17. sept 2025, 18:38 UTC

Market Talk

U.S. Natural Gas Futures Mixed Ahead of Storage Data -- Market Talk

17. sept 2025, 18:20 UTC

Market Talk

Gold Dips After Quarter-Point Rate Cut -- Market Talk

17. sept 2025, 18:18 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. sept 2025, 18:18 UTC

Market Talk

Treasury Yields, Dollar Fall on Nearly Unanimous Fed Cut -- Market Talk

17. sept 2025, 18:14 UTC

Market Talk

Oil Slips Some More as Fed Makes Expected 25 Bp Rate Cut -- Market Talk

17. sept 2025, 17:59 UTC

Market Talk

Soyoil Takes Hit as Traders Consider EPA Proposal -- Market Talk

17. sept 2025, 17:15 UTC

Omandamised, ülevõtmised, äriostud

Netflix 'Has Won The Streaming Wars,' Analyst Says. The Stock Is a Buy. -- Barrons.com

17. sept 2025, 17:06 UTC

Omandamised, ülevõtmised, äriostud

Walmart Stock Heads for a Record High. The Retailer Could Become a Leader in 'Agentic' AI. -- Barrons.com

17. sept 2025, 16:51 UTC

Tulu

Correct: Exor 1H Net Loss -EUR624M

17. sept 2025, 16:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. sept 2025, 16:34 UTC

Market Talk

Bank of Canada Ditches Resilience Talk, Plays Up Slowing Growth -- Market Talk

17. sept 2025, 16:25 UTC

Tulu

Wolters Kluwer: July, August Saw a Slight Increase in Organic Growth Compared to 1H

17. sept 2025, 16:23 UTC

Tulu

Wolters Kluwer: Year-to-Date Performance In Line With 2025 Guidance

Võrdlus sarnastega

Hinnamuutus

Medpace Holdings Inc Prognoos

Hinnasiht

By TipRanks

-14.34% langus

12 kuu keskmine prognoos

Keskmine 420.4 USD -14.34%

Kõrge 510 USD

Madal 300 USD

Põhineb 11 Wall Streeti analüütiku instrumendi Medpace Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

11 ratings

Osta

Hoia

Müü

Põhineb 11 analüütiku instrumendi Medpace Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

300 / 302.88Toetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

353 / 371 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.